Your search returned 137 studies:
- Sibling Donor Peripheral Stem Cell Transplant or Sibling Donor Bone Marrow Transplant in Treating Patients With Hematologic Cancers or Other Diseases
Conditions: Chronic Myeloproliferative Disorders - Graft Versus Host Disease - Leukemia - Lymphoma - Myelodysplastic Syndromes - Secondary Myelofibrosis
Location: Seattle, Washington
- Autologous Stem Cell Transplant Followed By Donor Stem Cell Transplant In Treating Patients With Relapsed or Refractory Lymphoma
Conditions: Adult Nasal Type Extranodal NK/T-cell Lymphoma - Anaplastic Large Cell Lymphoma - Angioimmunoblastic T-cell Lymphoma - Burkitt Lymphoma - Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue - Nodal Marginal Zone B-cell Lymphoma -
Location: Seattle, Washington
- Autologous Stem Cell Transplant Followed By Donor Stem Cell Transplant In Treating Patients With Relapsed or Refractory Lymphoma
Conditions: Adult Nasal Type Extranodal NK/T-cell Lymphoma - Anaplastic Large Cell Lymphoma - Angioimmunoblastic T-cell Lymphoma - Burkitt Lymphoma - Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue - Nodal Marginal Zone B-cell Lymphoma -
Location: Seattle, Washington
- Rituximab and Combination Chemotherapy in Treating Patients With Diffuse Large B-Cell Non-Hodgkin's Lymphoma
Conditions: Lymphoma
Location: Tacoma, Washington
- Fludeoxyglucose F 18-PET/CT Imaging and Combination Chemotherapy With or Without Additional Chemotherapy and G-CSF in Treating Patients With Stage III
Conditions: Lymphoma
Location: Bellevue, Washington
- Fludeoxyglucose F 18-PET/CT Imaging and Combination Chemotherapy With or Without Additional Chemotherapy and G-CSF in Treating Patients With Stage III
Conditions: Lymphoma
Location: Bremerton, Washington
- Fludeoxyglucose F 18-PET/CT Imaging and Combination Chemotherapy With or Without Additional Chemotherapy and G-CSF in Treating Patients With Stage III
Conditions: Lymphoma
Location: Burien, Washington
- Fludeoxyglucose F 18-PET/CT Imaging and Combination Chemotherapy With or Without Additional Chemotherapy and G-CSF in Treating Patients With Stage III
Conditions: Lymphoma
Location: Everett, Washington
- Fludeoxyglucose F 18-PET/CT Imaging and Combination Chemotherapy With or Without Additional Chemotherapy and G-CSF in Treating Patients With Stage III
Conditions: Lymphoma
Location: Federal Way, Washington
- Fludeoxyglucose F 18-PET/CT Imaging and Combination Chemotherapy With or Without Additional Chemotherapy and G-CSF in Treating Patients With Stage III
Conditions: Lymphoma
Location: Olympia, Washington
- Fludeoxyglucose F 18-PET/CT Imaging and Combination Chemotherapy With or Without Additional Chemotherapy and G-CSF in Treating Patients With Stage III
Conditions: Lymphoma
Location: Poulsbo, Washington
- Fludeoxyglucose F 18-PET/CT Imaging and Combination Chemotherapy With or Without Additional Chemotherapy and G-CSF in Treating Patients With Stage III
Conditions: Lymphoma
Location: Puyallup, Washington
- Fludeoxyglucose F 18-PET/CT Imaging and Combination Chemotherapy With or Without Additional Chemotherapy and G-CSF in Treating Patients With Stage III
Conditions: Lymphoma
Location: Seattle, Washington
- Fludeoxyglucose F 18-PET/CT Imaging and Combination Chemotherapy With or Without Additional Chemotherapy and G-CSF in Treating Patients With Stage III
Conditions: Lymphoma
Location: Seattle, Washington
- Fludeoxyglucose F 18-PET/CT Imaging and Combination Chemotherapy With or Without Additional Chemotherapy and G-CSF in Treating Patients With Stage III
Conditions: Lymphoma
Location: Seattle, Washington
- Fludeoxyglucose F 18-PET/CT Imaging and Combination Chemotherapy With or Without Additional Chemotherapy and G-CSF in Treating Patients With Stage III
Conditions: Lymphoma
Location: Seattle, Washington
- Fludeoxyglucose F 18-PET/CT Imaging and Combination Chemotherapy With or Without Additional Chemotherapy and G-CSF in Treating Patients With Stage III
Conditions: Lymphoma
Location: Seattle, Washington
- Fludeoxyglucose F 18-PET/CT Imaging and Combination Chemotherapy With or Without Additional Chemotherapy and G-CSF in Treating Patients With Stage III
Conditions: Lymphoma
Location: Seattle, Washington
- Fludeoxyglucose F 18-PET/CT Imaging and Combination Chemotherapy With or Without Additional Chemotherapy and G-CSF in Treating Patients With Stage III
Conditions: Lymphoma
Location: Tacoma, Washington
- Fludeoxyglucose F 18-PET/CT Imaging and Combination Chemotherapy With or Without Additional Chemotherapy and G-CSF in Treating Patients With Stage III
Conditions: Lymphoma
Location: Tacoma, Washington
- Fludeoxyglucose F 18-PET/CT Imaging and Combination Chemotherapy With or Without Additional Chemotherapy and G-CSF in Treating Patients With Stage III
Conditions: Lymphoma
Location: Tacoma, Washington
- Fludeoxyglucose F 18-PET/CT Imaging and Combination Chemotherapy With or Without Additional Chemotherapy and G-CSF in Treating Patients With Stage III
Conditions: Lymphoma
Location: Tacoma, Washington
- Fludeoxyglucose F 18-PET/CT Imaging and Combination Chemotherapy With or Without Additional Chemotherapy and G-CSF in Treating Patients With Stage III
Conditions: Lymphoma
Location: Tacoma, Washington
- Fludeoxyglucose F 18-PET/CT Imaging and Combination Chemotherapy With or Without Additional Chemotherapy and G-CSF in Treating Patients With Stage III
Conditions: Lymphoma
Location: Tacoma, Washington
- Iodine I 131 Monoclonal Antibody BC8 Before Autologous Stem Cell Transplant in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma or Non-H
Conditions: Adult Nasal Type Extranodal NK/T-cell Lymphoma - Anaplastic Large Cell Lymphoma - Angioimmunoblastic T-cell Lymphoma - Cutaneous B-cell Non-Hodgkin Lymphoma - Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue - Hepatosplenic T-
Location: Seattle, Washington
- Collecting and Storing Samples of Bone Marrow and Blood From Patients With Relapsed Acute Lymphoblastic Leukemia or Non-Hodgkin Lymphoma
Conditions: Leukemia - Lymphoma
Location: Seattle, Washington
- Collecting and Storing Samples of Bone Marrow and Blood From Patients With Relapsed Acute Lymphoblastic Leukemia or Non-Hodgkin Lymphoma
Conditions: Leukemia - Lymphoma
Location: Tacoma, Washington
- Collecting and Storing Biological Samples From Young Patients With Hodgkin's Lymphoma
Conditions: Lymphoma
Location: Seattle, Washington
- Collecting and Storing Biological Samples From Young Patients With Hodgkin's Lymphoma
Conditions: Lymphoma
Location: Tacoma, Washington
- Vorinostat, Fludarabine Phosphate, Cyclophosphamide, and Rituximab in Treating Patients With Previously Untreated Chronic Lymphocytic Leukemia or Smal
Conditions: B-cell Chronic Lymphocytic Leukemia - Contiguous Stage II Small Lymphocytic Lymphoma - Noncontiguous Stage II Small Lymphocytic Lymphoma - Stage I Chronic Lymphocytic Leukemia - Stage I Small Lymphocytic Lymphoma - Stage II Chronic Lymphocytic Leukemia -
Location: Seattle, Washington
- Vorinostat, Fludarabine Phosphate, Cyclophosphamide, and Rituximab in Treating Patients With Previously Untreated Chronic Lymphocytic Leukemia or Smal
Conditions: B-cell Chronic Lymphocytic Leukemia - Contiguous Stage II Small Lymphocytic Lymphoma - Noncontiguous Stage II Small Lymphocytic Lymphoma - Stage I Chronic Lymphocytic Leukemia - Stage I Small Lymphocytic Lymphoma - Stage II Chronic Lymphocytic Leukemia -
Location: Seattle, Washington
- Study to Assess the Effectiveness of RCHOP With or Without VELCADE in Previously Untreated Non-Germinal Center B-Cell-like Diffuse Large B-Cell Lympho
Conditions: Non-Germinal B-Cell-like (GCB) Diffuse Large B-cell Lymphoma (DLBCL)
Location: Edmonds, Washington
- Crizotinib in Treating Young Patients With Relapsed or Refractory Solid Tumors or Anaplastic Large Cell Lymphoma
Conditions: Brain and Central Nervous System Tumors - Lymphoma - Neuroblastoma - Unspecified Childhood Solid Tumor, Protocol Specific
Location: Seattle, Washington
- Collecting and Storing Tissue Samples From Patients With Rare or Cutaneous Non-Hodgkin Lymphoma
Conditions: Lymphoma - Lymphoproliferative Disorder
Location: Seattle, Washington
- A Study to Investigate the Efficacy and Safety of Bendamustine Compared With Bendamustine+RO5072759 (GA101) in Patients With Rituximab-Refractory, Ind
Conditions: Non-Hodgkin's Lymphoma
Location: Seattle, Washington
- First in Human Study to Determine the Safety, Tolerability and Preliminary Efficacy of an Anti-CXCR4 Antibody in Subjects With Acute Myelogenous Leuke
Conditions: Acute Myelogenous Leukemia - Diffuse Large B-Cell Leukemia - Chronic Lymphocytic Leukemia - Follicular Lymphoma
Location: Seattle, Washington
- Chemotherapy Based on Positron Emission Tomography Scan in Treating Patients With Stage I or Stage II Hodgkin Lymphoma
Conditions: Lymphoma
Location: Seattle, Washington
- Bortezomib and Rituximab in Treating Patients With Mantle Cell Lymphoma Who Have Previously Undergone Stem Cell Transplantation
Conditions: Contiguous Stage II Mantle Cell Lymphoma - Noncontiguous Stage II Mantle Cell Lymphoma - Recurrent Mantle Cell Lymphoma - Stage I Mantle Cell Lymphoma - Stage III Mantle Cell Lymphoma - Stage IV Mantle Cell Lymphoma
Location: Seattle, Washington
- Imetelstat Sodium in Treating Young Patients With Refractory or Recurrent Solid Tumors or Lymphoma
Conditions: Brain and Central Nervous System Tumors - Lymphoma - Lymphoproliferative Disorder - Small Intestine Cancer - Unspecified Childhood Solid Tumor, Protocol Specific
Location: Seattle, Washington
- A Study of Escalating Doses of DCDS4501A in Patients With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma and Chronic Lymphocytic Leukemia and DC
Conditions: Non-Hodgkin's Lymphoma, Chronic Lymphocytic Leukemia
Location: Seattle, Washington
- PET-Directed Therapy in Treating Patients With Limited-Stage Diffuse Large B-Cell Lymphoma
Conditions: Lymphoma
Location: Bremerton, Washington
- PET-Directed Therapy in Treating Patients With Limited-Stage Diffuse Large B-Cell Lymphoma
Conditions: Lymphoma
Location: Burien, Washington
- PET-Directed Therapy in Treating Patients With Limited-Stage Diffuse Large B-Cell Lymphoma
Conditions: Lymphoma
Location: Poulsbo, Washington
- PET-Directed Therapy in Treating Patients With Limited-Stage Diffuse Large B-Cell Lymphoma
Conditions: Lymphoma
Location: Seattle, Washington
- PET-Directed Therapy in Treating Patients With Limited-Stage Diffuse Large B-Cell Lymphoma
Conditions: Lymphoma
Location: Seattle, Washington
- PET-Directed Therapy in Treating Patients With Limited-Stage Diffuse Large B-Cell Lymphoma
Conditions: Lymphoma
Location: Seattle, Washington
- PET-Directed Therapy in Treating Patients With Limited-Stage Diffuse Large B-Cell Lymphoma
Conditions: Lymphoma
Location: Seattle, Washington
- PET-Directed Therapy in Treating Patients With Limited-Stage Diffuse Large B-Cell Lymphoma
Conditions: Lymphoma
Location: Seattle, Washington
- PET-Directed Therapy in Treating Patients With Limited-Stage Diffuse Large B-Cell Lymphoma
Conditions: Lymphoma
Location: Seattle, Washington
- PET-Directed Therapy in Treating Patients With Limited-Stage Diffuse Large B-Cell Lymphoma
Conditions: Lymphoma
Location: Seattle, Washington
- Phase 2 Safety and Efficacy Study of CAL-101 (GS-1101) in Relapsed or Refractory Hodgkin Lymphoma
Conditions: Hodgkin Lymphoma
Location: Seattle, Washington
- Rituximab With Combination Chemotherapy or Bendamustine Hydrochloride Followed by Consolidation Chemotherapy and Stem Cell Transplantation in Older Pa
Conditions: Lymphoma
Location: Bellevue, Washington
- Rituximab With Combination Chemotherapy or Bendamustine Hydrochloride Followed by Consolidation Chemotherapy and Stem Cell Transplantation in Older Pa
Conditions: Lymphoma
Location: Bremerton, Washington
- Rituximab With Combination Chemotherapy or Bendamustine Hydrochloride Followed by Consolidation Chemotherapy and Stem Cell Transplantation in Older Pa
Conditions: Lymphoma
Location: Burien, Washington
- Rituximab With Combination Chemotherapy or Bendamustine Hydrochloride Followed by Consolidation Chemotherapy and Stem Cell Transplantation in Older Pa
Conditions: Lymphoma
Location: Everett, Washington
- Rituximab With Combination Chemotherapy or Bendamustine Hydrochloride Followed by Consolidation Chemotherapy and Stem Cell Transplantation in Older Pa
Conditions: Lymphoma
Location: Federal Way, Washington
- Rituximab With Combination Chemotherapy or Bendamustine Hydrochloride Followed by Consolidation Chemotherapy and Stem Cell Transplantation in Older Pa
Conditions: Lymphoma
Location: Issaquah, Washington
- Rituximab With Combination Chemotherapy or Bendamustine Hydrochloride Followed by Consolidation Chemotherapy and Stem Cell Transplantation in Older Pa
Conditions: Lymphoma
Location: Olympia, Washington
- Rituximab With Combination Chemotherapy or Bendamustine Hydrochloride Followed by Consolidation Chemotherapy and Stem Cell Transplantation in Older Pa
Conditions: Lymphoma
Location: Poulsbo, Washington
- Rituximab With Combination Chemotherapy or Bendamustine Hydrochloride Followed by Consolidation Chemotherapy and Stem Cell Transplantation in Older Pa
Conditions: Lymphoma
Location: Puyallup, Washington
- Rituximab With Combination Chemotherapy or Bendamustine Hydrochloride Followed by Consolidation Chemotherapy and Stem Cell Transplantation in Older Pa
Conditions: Lymphoma
Location: Seattle, Washington
- Rituximab With Combination Chemotherapy or Bendamustine Hydrochloride Followed by Consolidation Chemotherapy and Stem Cell Transplantation in Older Pa
Conditions: Lymphoma
Location: Seattle, Washington
- Rituximab With Combination Chemotherapy or Bendamustine Hydrochloride Followed by Consolidation Chemotherapy and Stem Cell Transplantation in Older Pa
Conditions: Lymphoma
Location: Seattle, Washington
- Rituximab With Combination Chemotherapy or Bendamustine Hydrochloride Followed by Consolidation Chemotherapy and Stem Cell Transplantation in Older Pa
Conditions: Lymphoma
Location: Seattle, Washington
- Rituximab With Combination Chemotherapy or Bendamustine Hydrochloride Followed by Consolidation Chemotherapy and Stem Cell Transplantation in Older Pa
Conditions: Lymphoma
Location: Seattle, Washington
- Rituximab With Combination Chemotherapy or Bendamustine Hydrochloride Followed by Consolidation Chemotherapy and Stem Cell Transplantation in Older Pa
Conditions: Lymphoma
Location: Seattle, Washington
- Rituximab With Combination Chemotherapy or Bendamustine Hydrochloride Followed by Consolidation Chemotherapy and Stem Cell Transplantation in Older Pa
Conditions: Lymphoma
Location: Seattle, Washington
- Rituximab With Combination Chemotherapy or Bendamustine Hydrochloride Followed by Consolidation Chemotherapy and Stem Cell Transplantation in Older Pa
Conditions: Lymphoma
Location: Tacoma, Washington
- Rituximab With Combination Chemotherapy or Bendamustine Hydrochloride Followed by Consolidation Chemotherapy and Stem Cell Transplantation in Older Pa
Conditions: Lymphoma
Location: Tacoma, Washington
- Rituximab With Combination Chemotherapy or Bendamustine Hydrochloride Followed by Consolidation Chemotherapy and Stem Cell Transplantation in Older Pa
Conditions: Lymphoma
Location: Tacoma, Washington
- Rituximab With Combination Chemotherapy or Bendamustine Hydrochloride Followed by Consolidation Chemotherapy and Stem Cell Transplantation in Older Pa
Conditions: Lymphoma
Location: Tacoma, Washington
- Rituximab With Combination Chemotherapy or Bendamustine Hydrochloride Followed by Consolidation Chemotherapy and Stem Cell Transplantation in Older Pa
Conditions: Lymphoma
Location: Tacoma, Washington
- Combined Rituximab and Lenalidomide Treatment for Untreated Patients With Follicular Lymphoma
Conditions: Follicular Lymphoma
Location: Seattle, Washington
- Alisertib (MLN8237) or Investigator's Choice in Patients With Relapsed/Refractory Peripheral T-Cell Lymphoma
Conditions: Relapsed Peripheral T-Cell Lymphoma - Refractory Peripheral T-Cell Lymphoma
Location: Seattle, Washington
- Double Cord Versus Haploidentical (Blood and Marrow Transplant Clinical Trials Network #1101)
Conditions: Acute Lymphocytic Leukemia - Acute Myelogenous Leukemia - Burkitt's Lymphoma - Follicular Lymphoma - Hodgkin Lymphoma - Mantle Cell Lymphoma
Location: Seattle, Washington
- Combination Chemotherapy With or Without Autologous Stem Cell Transplant in Treating Patients With Central Nervous System B-Cell Lymphoma
Conditions: Lymphoma
Location: Seattle, Washington
- Combination Chemotherapy With or Without Autologous Stem Cell Transplant in Treating Patients With Central Nervous System B-Cell Lymphoma
Conditions: Lymphoma
Location: Seattle, Washington
- Combination Chemotherapy With or Without Autologous Stem Cell Transplant in Treating Patients With Central Nervous System B-Cell Lymphoma
Conditions: Lymphoma
Location: Seattle, Washington
- Mass Balance, Pharmacokinetics and Metabolism Study of Alisertib
Conditions: Advanced Solid Tumors - Lymphoma
Location: Tacoma, Washington
- Fludarabine Phosphate, Radiation Therapy, and Rituximab in Treating Patients Who Are Undergoing Donor Stem Cell Transplant Followed by Rituximab for H
Conditions: B-cell Chronic Lymphocytic Leukemia - Prolymphocytic Leukemia - Recurrent Small Lymphocytic Lymphoma - Refractory Chronic Lymphocytic Leukemia - Stage III Chronic Lymphocytic Leukemia - Stage III Small Lymphocytic Lymphoma - Stage IV Chronic Lymphocytic L
Location: Seattle, Washington
- Fludarabine Phosphate, Radiation Therapy, and Rituximab in Treating Patients Who Are Undergoing Donor Stem Cell Transplant Followed by Rituximab for H
Conditions: B-cell Chronic Lymphocytic Leukemia - Prolymphocytic Leukemia - Recurrent Small Lymphocytic Lymphoma - Refractory Chronic Lymphocytic Leukemia - Stage III Chronic Lymphocytic Leukemia - Stage III Small Lymphocytic Lymphoma - Stage IV Chronic Lymphocytic L
Location: Seattle, Washington
- Combination Chemotherapy in Treating Young Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma
Conditions: Contiguous Stage II Adult Lymphoblastic Lymphoma - Noncontiguous Stage II Adult Lymphoblastic Lymphoma - Stage II Adult T-cell Leukemia/Lymphoma - Stage II Childhood Lymphoblastic Lymphoma - Stage III Adult Lymphoblastic Lymphoma - Stage III Adult T-cell
Location: Seattle, Washington
- Combination Chemotherapy in Treating Young Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma
Conditions: Contiguous Stage II Adult Lymphoblastic Lymphoma - Noncontiguous Stage II Adult Lymphoblastic Lymphoma - Stage II Adult T-cell Leukemia/Lymphoma - Stage II Childhood Lymphoblastic Lymphoma - Stage III Adult Lymphoblastic Lymphoma - Stage III Adult T-cell
Location: Tacoma, Washington
- Combination Chemotherapy in Treating Young Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma
Conditions: Contiguous Stage II Adult Lymphoblastic Lymphoma - Noncontiguous Stage II Adult Lymphoblastic Lymphoma - Stage II Adult T-cell Leukemia/Lymphoma - Stage II Childhood Lymphoblastic Lymphoma - Stage III Adult Lymphoblastic Lymphoma - Stage III Adult T-cell
Location: Tacoma, Washington
- Bortezomib, Ifosfamide, Carboplatin, and Etoposide, With or Without Rituximab, in Treating Patients With Relapsed or Refractory AIDS-Related Non-Hodgk
Conditions: Lymphoma
Location: Seattle, Washington
- Detecting Anal and Genital Human Papillomavirus Infection and Squamous Intraepithelial Lesions in HIV-Positive Patients Enrolled in AIDS Cancer Clinic
Conditions: Aids-related Malignancies - Lymphoma - Precancerous Condition - Sarcoma
Location: Seattle, Washington
- Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies
Conditions: Accelerated Phase Chronic Myelogenous Leukemia - Acute Myeloid Leukemia/Transient Myeloproliferative Disorder - Acute Undifferentiated Leukemia - Angioimmunoblastic T-cell Lymphoma - Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative - Blastic Phase Chr
Location: Seattle, Washington
- Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies
Conditions: Accelerated Phase Chronic Myelogenous Leukemia - Acute Myeloid Leukemia/Transient Myeloproliferative Disorder - Acute Undifferentiated Leukemia - Angioimmunoblastic T-cell Lymphoma - Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative - Blastic Phase Chr
Location: Tacoma, Washington
- Rituximab in Treating Patients Undergoing Donor Peripheral Blood Stem Cell Transplant for Relapsed or Refractory B-Cell Lymphoma
Conditions: Childhood Diffuse Large Cell Lymphoma - Childhood Immunoblastic Large Cell Lymphoma - Cutaneous B-cell Non-Hodgkin Lymphoma - Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue - Intraocular Lymphoma - Nodal Marginal Zone B-cell
Location: Seattle, Washington
- Bortezomib and Combination Chemotherapy in Treating Young Patients With Relapsed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
Conditions: Leukemia - Lymphoma
Location: Seattle, Washington
- Bortezomib and Combination Chemotherapy in Treating Young Patients With Relapsed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
Conditions: Leukemia - Lymphoma
Location: Tacoma, Washington
- Bortezomib and Combination Chemotherapy in Treating Young Patients With Relapsed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
Conditions: Leukemia - Lymphoma
Location: Tacoma, Washington
- Vorinostat in Patients With Primary Cutaneous T-Cell Lymphoma
Conditions: Stage I Cutaneous T-cell Non-Hodgkin Lymphoma - Stage I Mycosis Fungoides/Sezary Syndrome - Stage II Cutaneous T-cell Non-Hodgkin Lymphoma - Stage II Mycosis Fungoides/Sezary Syndrome - Stage III Cutaneous T-cell Non-Hodgkin Lymphoma - Stage III Mycosis F
Location: Seattle, Washington
- Immune Response After Stem Cell Transplant in HIV-Positive Patients With Hematologic Cancer
Conditions: Accelerated Phase Chronic Myelogenous Leukemia - Adult Acute Lymphoblastic Leukemia in Remission - Adult Acute Myeloid Leukemia in Remission - Adult Nasal Type Extranodal NK/T-cell Lymphoma - AIDS-related Diffuse Large Cell Lymphoma - AIDS-related Diffuse
Location: Seattle, Washington
- Vorinostat, Rituximab, and Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Diffuse Large B-Cell Ly
Conditions: Contiguous Stage II Adult Diffuse Large Cell Lymphoma - Noncontiguous Stage II Adult Diffuse Large Cell Lymphoma - Stage III Adult Diffuse Large Cell Lymphoma - Stage IV Adult Diffuse Large Cell Lymphoma
Location: Bremerton, Washington
- Vorinostat, Rituximab, and Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Diffuse Large B-Cell Ly
Conditions: Contiguous Stage II Adult Diffuse Large Cell Lymphoma - Noncontiguous Stage II Adult Diffuse Large Cell Lymphoma - Stage III Adult Diffuse Large Cell Lymphoma - Stage IV Adult Diffuse Large Cell Lymphoma
Location: Burien, Washington
- Vorinostat, Rituximab, and Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Diffuse Large B-Cell Ly
Conditions: Contiguous Stage II Adult Diffuse Large Cell Lymphoma - Noncontiguous Stage II Adult Diffuse Large Cell Lymphoma - Stage III Adult Diffuse Large Cell Lymphoma - Stage IV Adult Diffuse Large Cell Lymphoma
Location: Issaquah, Washington
- Vorinostat, Rituximab, and Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Diffuse Large B-Cell Ly
Conditions: Contiguous Stage II Adult Diffuse Large Cell Lymphoma - Noncontiguous Stage II Adult Diffuse Large Cell Lymphoma - Stage III Adult Diffuse Large Cell Lymphoma - Stage IV Adult Diffuse Large Cell Lymphoma
Location: Poulsbo, Washington
- Vorinostat, Rituximab, and Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Diffuse Large B-Cell Ly
Conditions: Contiguous Stage II Adult Diffuse Large Cell Lymphoma - Noncontiguous Stage II Adult Diffuse Large Cell Lymphoma - Stage III Adult Diffuse Large Cell Lymphoma - Stage IV Adult Diffuse Large Cell Lymphoma
Location: Seattle, Washington
- Vorinostat, Rituximab, and Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Diffuse Large B-Cell Ly
Conditions: Contiguous Stage II Adult Diffuse Large Cell Lymphoma - Noncontiguous Stage II Adult Diffuse Large Cell Lymphoma - Stage III Adult Diffuse Large Cell Lymphoma - Stage IV Adult Diffuse Large Cell Lymphoma
Location: Seattle, Washington
- Vorinostat, Rituximab, and Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Diffuse Large B-Cell Ly
Conditions: Contiguous Stage II Adult Diffuse Large Cell Lymphoma - Noncontiguous Stage II Adult Diffuse Large Cell Lymphoma - Stage III Adult Diffuse Large Cell Lymphoma - Stage IV Adult Diffuse Large Cell Lymphoma
Location: Seattle, Washington
- Vorinostat, Rituximab, and Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Diffuse Large B-Cell Ly
Conditions: Contiguous Stage II Adult Diffuse Large Cell Lymphoma - Noncontiguous Stage II Adult Diffuse Large Cell Lymphoma - Stage III Adult Diffuse Large Cell Lymphoma - Stage IV Adult Diffuse Large Cell Lymphoma
Location: Seattle, Washington
- Vorinostat, Rituximab, and Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Diffuse Large B-Cell Ly
Conditions: Contiguous Stage II Adult Diffuse Large Cell Lymphoma - Noncontiguous Stage II Adult Diffuse Large Cell Lymphoma - Stage III Adult Diffuse Large Cell Lymphoma - Stage IV Adult Diffuse Large Cell Lymphoma
Location: Seattle, Washington
- Vorinostat, Rituximab, and Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Diffuse Large B-Cell Ly
Conditions: Contiguous Stage II Adult Diffuse Large Cell Lymphoma - Noncontiguous Stage II Adult Diffuse Large Cell Lymphoma - Stage III Adult Diffuse Large Cell Lymphoma - Stage IV Adult Diffuse Large Cell Lymphoma
Location: Seattle, Washington
- Trial of Nelarabine, Etoposide and Cyclophosphamide in Relapsed T-cell ALL and T-cell LL
Conditions: Relapsed T-Cell Acute Lymphoblastic Leukemia - Relapsed T-Cell Lymphoblastic Lymphoma
Location: Seattle, Washington
- Bortezomib and Vorinostat as Maintenance Therapy After Autologous Stem Cell Transplant for Non-Hodgkin Lymphoma
Conditions: Anaplastic Large Cell Lymphoma - Contiguous Stage II Adult Diffuse Large Cell Lymphoma - Contiguous Stage II Adult Diffuse Mixed Cell Lymphoma - Contiguous Stage II Adult Diffuse Small Cleaved Cell Lymphoma - Contiguous Stage II Grade 1 Follicular Lymphom
Location: Seattle, Washington
- Autologous Peripheral Blood Stem Cell Transplant Followed by Donor Bone Marrow Transplant in Treating Patients With High-Risk Hodgkin Lymphoma, Non-Ho
Conditions: Adult Nasal Type Extranodal NK/T-cell Lymphoma - Anaplastic Large Cell Lymphoma - Angioimmunoblastic T-cell Lymphoma - B-cell Chronic Lymphocytic Leukemia - Childhood Burkitt Lymphoma - Childhood Diffuse Large Cell Lymphoma - Childhood Immunoblastic Large
Location: Seattle, Washington
- Ofatumumab Versus Rituximab Salvage Chemoimmunotherapy Followed by Autologous Stem Cell Transplant in Relapsed or Refractory Diffuse Large B Cell Lymp
Conditions: Lymphoma, Large-Cell, Diffuse
Location: Seattle, Washington
- Study Evaluating Chemotherapy in Combination With Inotuzumab Ozogamicin In Subjects With Non-Hodgkin's Lymphoma
Conditions: Lymphoma, B-Cell
Location: Federal Way, Washington
- Study Evaluating Chemotherapy in Combination With Inotuzumab Ozogamicin In Subjects With Non-Hodgkin's Lymphoma
Conditions: Lymphoma, B-Cell
Location: Gig Harbor, Washington
- Study Evaluating Chemotherapy in Combination With Inotuzumab Ozogamicin In Subjects With Non-Hodgkin's Lymphoma
Conditions: Lymphoma, B-Cell
Location: Lakewood, Washington
- Study Evaluating Chemotherapy in Combination With Inotuzumab Ozogamicin In Subjects With Non-Hodgkin's Lymphoma
Conditions: Lymphoma, B-Cell
Location: Puyallup, Washington
- Study Evaluating Chemotherapy in Combination With Inotuzumab Ozogamicin In Subjects With Non-Hodgkin's Lymphoma
Conditions: Lymphoma, B-Cell
Location: Tacoma, Washington
- Ofatumumab and Bendamustine Combination Therapy Compared With Bendamustine Monotherapy in Indolent B-cell Non-Hodgkin's Lymphoma (NHL) Unresponsive to
Conditions: Lymphoma, Follicular
Location: Seattle, Washington
- Rituximab, Combination Chemotherapy, Filgrastim (G-CSF), and Plerixafor in Treating Patients With Non-Hodgkin Lymphoma Undergoing Mobilization of Auto
Conditions: Adult Grade III Lymphomatoid Granulomatosis - Adult Non-Hodgkin Lymphoma - Contiguous Stage II Adult Burkitt Lymphoma - Contiguous Stage II Adult Diffuse Large Cell Lymphoma - Contiguous Stage II Adult Diffuse Mixed Cell Lymphoma - Contiguous Stage II Adu
Location: Seattle, Washington
- Bendamustine Hydrochloride, Etoposide, Dexamethasone, and Filgrastim For Peripheral Blood Stem Cell Mobilization in Treating Patients With Refractory
Conditions: Adult Nasal Type Extranodal NK/T-cell Lymphoma - Anaplastic Large Cell Lymphoma - Angioimmunoblastic T-cell Lymphoma - Cutaneous B-cell Non-Hodgkin Lymphoma - Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue - Intraocular Lymp
Location: Seattle, Washington
- Autologous Transplant in HIV Patients (BMT CTN 0803)
Conditions: Lymphoma - HIV
Location: Seattle, Washington
- Bendamustine Hydrochloride, Rituximab, Etoposide, and Carboplatin in Treating Patients With Relapsed or Refractory Lymphoid Malignancies and Select Un
Conditions: Adult Grade III Lymphomatoid Granulomatosis - Adult Nasal Type Extranodal NK/T-cell Lymphoma - Anaplastic Large Cell Lymphoma - Angioimmunoblastic T-cell Lymphoma - Chronic Lymphocytic Leukemia - Contiguous Stage II Adult Diffuse Mixed Cell Lymphoma - Con
Location: Seattle, Washington
- Single Agent Ofatumumab Vs. Single Agent Rituximab in Follicular Lymphoma Relapsed After Rituximab-Containing Therapy
Conditions: Lymphoma, Follicular
Location: Seattle, Washington
- A Dose Finding Study With Oral LDK378 in Patients With Tumors Characterized by Genetic Abnormalities in Anaplastic Lymphoma Kinase (ALK)
Conditions: Tumors Characterized by Genetic Abnormalities of ALK
Location: Seattle, Washington
- A Study Of PF-05082566 As A Single Agent And In Combination With Rituximab
Conditions: Lymphoma, Non-Hodgkin
Location: Seattle, Washington
- A Phase 1 Study Evaluating the Safety and Pharmacokinetics of ABT-199 in Subjects With Relapsed or Refractory Chronic Lymphocytic Leukemia and Non-Hod
Conditions: Chronic Lymphocytic Leukemia - Non-Hodgkin Lymphoma
Location: Seattle, Washington
- Lenalidomide With or Without Rituximab in Treating Patients With Progressive or Relapsed Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Pro
Conditions: Adult Nasal Type Extranodal NK/T-cell Lymphoma - Anaplastic Large Cell Lymphoma - Angioimmunoblastic T-cell Lymphoma - Cutaneous B-cell Non-Hodgkin Lymphoma - Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue - Hepatosplenic T-
Location: Seattle, Washington
- A Study of Brentuximab Vedotin in Relapsed or Refractory CD30-positive Non-Hodgkin Lymphoma
Conditions: Lymphoma, B-Cell - Lymphoma, Large B-Cell, Diffuse - Lymphoma, Non-Hodgkin - Lymphoma, T-Cell
Location: Edmonds, Washington
- A Study of Brentuximab Vedotin in Relapsed or Refractory CD30-positive Non-Hodgkin Lymphoma
Conditions: Lymphoma, B-Cell - Lymphoma, Large B-Cell, Diffuse - Lymphoma, Non-Hodgkin - Lymphoma, T-Cell
Location: Seattle, Washington
- High-Dose Y-90-Ibritumomab Tiuxetan Added to Reduced-Intensity Allogeneic Stem Cell Transplant Regimen for Relapsed or Refractory Aggressive B-Cell Ly
Conditions: Post-transplant Lymphoproliferative Disorder - Recurrent Adult Burkitt Lymphoma - Recurrent Adult Diffuse Large Cell Lymphoma - Recurrent Adult Diffuse Mixed Cell Lymphoma - Recurrent Adult Grade III Lymphomatoid Granulomatosis - Recurrent Adult Immunobla
Location: Seattle, Washington
- Brentuximab Vedotin in Patients With CD30-positive Nonlymphomatous Malignancies
Conditions: Acute Lymphoid Leukemia - Acute Myeloid Leukemia - Chronic Lymphocytic Leukemia - Multiple Myeloma - Solid Tumors
Location: Edmonds, Washington
- A Phase 3 Study of Ibrutinib (PCI-32765) Versus Ofatumumab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia
Conditions: Relapsed or Refractory Chronic Lymphocytic Leukemia - Small Lymphocytic Lymphoma
Location: Seattle, Washington
- CD19 CAR T Cells for B Cell Malignancies After Allogeneic Transplant
Conditions: Philadelphia Chromosome Negative Adult Precursor Acute Lymphoblastic Leukemia - Recurrent Adult Acute Lymphoblastic Leukemia - Recurrent Adult Diffuse Large Cell Lymphoma - Recurrent Adult Immunoblastic Large Cell Lymphoma - Recurrent Mantle Cell Lymphoma
Location: Seattle, Washington
- Monoclonal Antibody Therapy Before Stem Cell Transplant in Treating Patients With Relapsed or Refractory Lymphoid Malignancies
Conditions: Adult Nasal Type Extranodal NK/T-cell Lymphoma - Anaplastic Large Cell Lymphoma - Angioimmunoblastic T-cell Lymphoma - Cutaneous B-cell Non-Hodgkin Lymphoma - Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue - Hepatosplenic T-
Location: Seattle, Washington
- Brentuximab Vedotin in Treating Patients With Relapsed or Refractory CD30+ Lymphoma
Conditions: Adult Grade III Lymphomatoid Granulomatosis - Adult Nasal Type Extranodal NK/T-cell Lymphoma - Anaplastic Large Cell Lymphoma - Angioimmunoblastic T-cell Lymphoma - Cutaneous B-cell Non-Hodgkin Lymphoma - Extranodal Marginal Zone B-cell Lymphoma of Mucosa
Location: Seattle, Washington
- A Study of DCDT2980S in Combination With MabThera/Rituxan or DCDS4501A in Combination With MabThera/Rituxan in Patients With Non-Hodgkin's Lymphoma
Conditions: Lymphoma, B-Cell, Lymphoma, Follicular
Location: Seattle, Washington
- A Study Evaluating the Efficacy and Safety of Idelalisib (GS-1101) in Combination With Rituximab for Previously Treated Indolent Non-Hodgkin Lymphomas
Conditions: Indolent Non-Hodgkin's Lymphomas
Location: Tacoma, Washington
- ECHELON-2: A Comparison of Brentuximab Vedotin and CHP With Standard-of-care CHOP in the Treatment of Patients With CD30-positive Mature T-cell Lympho
Conditions: Lymphoma, Large-Cell, Anaplastic - Lymphoma, Non-Hodgkin - Lymphoma, T-Cell
Location: Seattle, Washington
- A Study Evaluating the Efficacy and Safety of Idelalisib(GS-1101) in Combination With Bendamustine and Rituximab for Previously Treated Indolent Non-H
Conditions: Indolent Non-Hodgkin's Lymphomas
Location: Tacoma, Washington
- A Phase 2 of GS-9973 in Combination With Idelalisib in Subjects With Relapsed or Refractory Hematologic Malignancies
Conditions: Chronic Lymphocytic Leukemia - Mantle Cell Lymphoma - Diffuse Large B-cell Lymphoma - Indolent Non-Hodgkin's Lymphoma
Location: Tacoma, Washington
- Feasibility of Assessing Lymphoma Response to Precise Local Injection of Candidate Chemotherapy Agents
Conditions: Lymphoma
Location: Seattle, Washington
|